X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (133) 133
Publication (10) 10
Newspaper Article (6) 6
Dissertation (5) 5
Patent (5) 5
Book / eBook (2) 2
Book Chapter (2) 2
Magazine Article (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35) 35
humans (34) 34
female (26) 26
male (21) 21
animals (18) 18
neurology (16) 16
middle aged (15) 15
pharmacology & pharmacy (13) 13
research (12) 12
aged (11) 11
health aspects (10) 10
neurosciences (10) 10
article (9) 9
clinical neurology (9) 9
inflammation (9) 9
rats (9) 9
risk (9) 9
usage (9) 9
analysis (8) 8
surgery (8) 8
biomarkers (7) 7
gene expression (7) 7
medicine, general & internal (7) 7
mice (7) 7
risk factors (7) 7
abridged index medicus (6) 6
adult (6) 6
alzheimer's disease (6) 6
alzheimers disease (6) 6
atherosclerosis (6) 6
care and treatment (6) 6
double-blind method (6) 6
expression (6) 6
nanoparticles (6) 6
physiological aspects (6) 6
stroke (6) 6
studies (6) 6
alzheimer disease - cerebrospinal fluid (5) 5
alzheimer disease - diagnosis (5) 5
alzheimer disease - genetics (5) 5
amyloid beta-peptides - cerebrospinal fluid (5) 5
animals, newborn (5) 5
cerebrospinal fluid (5) 5
dementia (5) 5
formulation (5) 5
genetics (5) 5
pediatrics (5) 5
performing operations (5) 5
postmenopausal women (5) 5
prevention (5) 5
rats, sprague-dawley (5) 5
transporting (5) 5
aged, 80 and over (4) 4
alzheimer disease - pathology (4) 4
biomarkers - cerebrospinal fluid (4) 4
brain - pathology (4) 4
breast-cancer (4) 4
chemistry (4) 4
child (4) 4
children (4) 4
ciprofloxacin hcl (4) 4
disease (4) 4
disease models, animal (4) 4
dose-response relationship, drug (4) 4
drugs (4) 4
gene expression regulation (4) 4
general tagging of cross-sectional technologies spanning over several sections of the ipc (4) 4
general tagging of new technological developments (4) 4
genes (4) 4
genetic aspects (4) 4
genome-wide association (4) 4
hematology (4) 4
hospitals (4) 4
in-vitro (4) 4
in-vivo (4) 4
ischemia (4) 4
layered products (4) 4
layered products, i.e. products built-up of strata of flat ornon-flat, e.g. cellular or honeycomb, form (4) 4
lipids (4) 4
medical research (4) 4
medicine, experimental (4) 4
medicine, research & experimental (4) 4
mice, knockout (4) 4
plasma (4) 4
regression analysis (4) 4
research article (4) 4
swine (4) 4
technical subjects covered by former us classification (4) 4
technical subjects covered by former uspc (4) 4
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (4) 4
treatment outcome (4) 4
adenosine (3) 3
after-treatment of the shaped products, e.g. repairing (3) 3
amyloid beta-peptides - blood (3) 3
amyloid beta-peptides - metabolism (3) 3
amyloid-beta (3) 3
analysis of variance (3) 3
apoptosis (3) 3
biology (3) 3
blood pressure (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, The, ISSN 1474-4422, 2012, Volume 11, Issue 12, pp. 1048 - 1056
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 1, p. e16032
Background: Ideally, disease modifying therapies for Alzheimer disease (AD) will be applied during the 'preclinical' stage (pathology present with cognition... 
CARBONIC-ANHYDRASE-IV | EPITHELIUM-DERIVED FACTOR | CELL-ADHESION MOLECULE | SECRETORY GRANULE MEMBRANE | MULTIDISCIPLINARY SCIENCES | CEREBRAL-ARTERY OCCLUSION | IMMUNODEFICIENCY-VIRUS ENCEPHALITIS | AMYLOID-BETA-PROTEIN | MILD COGNITIVE IMPAIRMENT | FRONTOTEMPORAL LOBAR DEGENERATION | GENOME-WIDE ASSOCIATION | Severity of Illness Index | Enzyme-Linked Immunosorbent Assay | Humans | Middle Aged | Dementia - diagnosis | Electrophoresis, Gel, Two-Dimensional | Male | Alzheimer Disease - cerebrospinal fluid | Case-Control Studies | Disease Progression | Alzheimer Disease - diagnosis | Tandem Mass Spectrometry | Aged, 80 and over | Female | ROC Curve | Aged | Biomarkers - cerebrospinal fluid | Cerebrospinal Fluid Proteins - analysis | Early Diagnosis | Enzymes | Advertising executives | Medical research | Care and treatment | Medicine, Experimental | Biological markers | Alzheimer's disease | Enzyme-linked immunosorbent assay | Cystatin | Multiple sclerosis | Physicians | Cognitive ability | Nervous system | Cognition | Cerebrospinal fluid | Cell adhesion & migration | Proteins | Confidence intervals | Immunology | Neurodegeneration | Cystatin C | Dementia disorders | Bioindicators | Trends | Neurological disorders | Statistical analysis | Neurodegenerative diseases | Gel electrophoresis | Transthyretin | Mass spectroscopy | Regression analysis | Behavioral sciences | Metabolism | Medicine | Pathology | Neurology | Brain research | Tau protein | Proteomics | Biomarkers | Diagnostic systems | Proteomes | Alzheimers disease | Mass spectrometry | Immunoassays | Dementia
Journal Article
PLoS Genetics, ISSN 1553-7390, 09/2010, Volume 6, Issue 9, p. e1001101
Alzheimer's Disease (AD) is a complex and multifactorial disease. While large genome-wide association studies have had some success in identifying novel... 
IDENTIFIES VARIANTS | COGNITIVE DECLINE | DEMENTIA | AMYLOID-BETA | GENETICS & HEREDITY | GENE-EXPRESSION | CALCINEURIN | BRAIN | GENOME-WIDE ASSOCIATION | PROGRESSIVE SUPRANUCLEAR PALSY | CORTICOBASAL DEGENERATION | Humans | Middle Aged | tau Proteins - metabolism | Male | Phosphoproteins - metabolism | RNA, Messenger - metabolism | Alzheimer Disease - pathology | Washington - epidemiology | Calcineurin - genetics | Amyloid beta-Peptides - metabolism | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Alzheimer Disease - epidemiology | Female | Biomarkers - metabolism | Genetic Predisposition to Disease | Peptide Fragments - metabolism | Reproducibility of Results | Peptide Fragments - cerebrospinal fluid | RNA, Messenger - genetics | Risk Factors | Gene Expression Regulation | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Phosphoproteins - cerebrospinal fluid | Disease Progression | Age of Onset | Survival Analysis | Polymorphism, Single Nucleotide - genetics | Aged | Alzheimer Disease - genetics | Calcineurin - metabolism | Allelomorphism | Care and treatment | Development and progression | Genetic aspects | Single nucleotide polymorphisms | Cerebrospinal fluid | Identification and classification | Alzheimer's disease | Genetics | Alzheimers disease | Pharmaceutical industry | Health risk assessment | Genes
Journal Article
Developmental Cell, ISSN 1534-5807, 01/2015, Volume 32, Issue 1, pp. 82 - 96
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 08/2005, Volume 289, Issue 2, pp. 558 - 568
Journal Article
Journal Article
Indian Journal of Anaesthesia, ISSN 0019-5049, 7/2019, Volume 63, Issue 7, pp. 565 - 570
Background and Aims: There have been various methods tested for reducing preoperative anxiety in children, but very limited literature is available in the... 
Children | Pediatric anesthesia | Surgery | Analysis | Multimedia | Intervention | Anxieties | Education | Anesthesia | Blood pressure | Psychologists | Patients | Age groups | Children & youth | smartphone | video | Preoperative anxiety | Original | visual analog scale for anxiety
Journal Article
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 11/2009, Volume 1, Issue 8‐9, pp. 371 - 380
Alzheimer's disease (AD) pathology is estimated to develop many years before detectable cognitive decline. Fluid and imaging biomarkers may identify people in... 
amyloid | biomarker | preclinical Alzheimer's disease | Pittsburgh compound B | cerebrospinal fluid | Biomarker | Amyloid | Cerebrospinal fluid | Preclinical Alzheimer's disease | Report
Journal Article